GenFleet Therapeutics (Shanghai) Inc is a biopharmaceutical company focused on developing novel treatment options in the fields of oncology, covering different lines of treatments of multiple solid… Genfleet (HKG: 02595) is based in Shanghai, China and was founded in 2017. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $800 million (Sep 2025). It has raised $205 million.
Last price · $/share
—
Implied valuation
$799.7M
Total raised
$204.8M
Last round
—
No prints on record
No secondary trades in Genfleet (HKG: 02595) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genfleet (HKG: 02595) with a free account
·Watch Genfleet (HKG: 02595): the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Genfleet (HKG: 02595) stock.
